Aethlon Medical (AEMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,378 | -2,571 | -12,208 | -9,783 | -6,317 |
| Depreciation Amortization | 311 | 85 | 359 | 275 | 184 |
| Other Working Capital | 853 | 600 | 479 | 860 | 439 |
| Other Operating Activity | 253 | 139 | 1,241 | 1,084 | 507 |
| Operating Cash Flow | $-3,962 | $-1,748 | $-10,130 | $-7,564 | $-5,187 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -251 | -246 | -237 |
| Investing Cash Flow | $N/A | $N/A | $-251 | $-246 | $-237 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,384 | 5,384 | 1,322 | 1,273 | 1,086 |
| Other Financing Activity | -9 | -5 | -35 | -28 | -18 |
| Financing Cash Flow | $5,375 | $5,379 | $1,288 | $1,245 | $1,068 |
| Exchange Rate Effect | 4 | -1 | 2 | 4 | -1 |
| Beginning Cash Position | 5,530 | 5,530 | 14,621 | 14,621 | 14,621 |
| End Cash Position | 6,947 | 9,160 | 5,530 | 8,060 | 10,263 |
| Net Cash Flow | $1,417 | $3,630 | $-9,091 | $-6,561 | $-4,357 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,962 | -1,748 | -10,130 | -7,564 | -5,187 |
| Capital Expenditure | N/A | N/A | -251 | -246 | -237 |
| Free Cash Flow | -3,962 | -1,748 | -10,381 | -7,810 | -5,424 |